| CAS ID: | 943764-99-6 |
| Molecular Formula: | C29H27N3O4 |
| Molecular Weight: | 481.6 g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C29H27N3O4/c33-29(34)23-5-1-20(2-6-23)16-31-18-25-15-24(31)19-32(25)17-21-3-9-26(10-4-21)36-27-11-7-22(8-12-27)28-30-13-14-35-28/h1-14,24-25H,15-19H2,(H,33,34)/t24-,25-/m0/s1 | See All |
| InChI Key: | GERJIEKMNDGSCS-DQEYMECFSA-N | |
| Smiles: | C1C2CN(C1CN2CC3=CC=C(C=C3)OC4=CC=C(C=C4)C5=NC=CO5)CC6=CC=C(C=C6)C(=O)O | See All |
| Molfile: |
Trial Record 1
| ClinicalTrial ID | NCT01944735 | Disease | Cystic fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | September 18, 2013 | Last Verified | March 6, 2015 |
| Sponsor | Celtaxsys, Inc. | ||
Trial Record 2
| ClinicalTrial ID | NCT02443688 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | May 14, 2015 | Last Verified | May 17, 2018 |
| Sponsor | Celtaxsys, Inc. | ||
| PubChem: | 68488178 |
| ChEMBL: |